|
PIP Initial Submission and use of IRIS from 04 June 2024
|
Luis Vaz
|
|
3 |
|
Creating a submission (any type) - issue in completing the submission
|
Anneke Luppes
|
|
1 |
|
IRIS Email Communications from EMA
|
Daniel Verrall
|
|
1 |
|
GCP inspection
|
Disha Dadke
|
|
1 |
|
Content submitted for a Preparatory SA meeting (Human)
|
Liron Gibbs-Bar
|
|
1 |
|
Marketing status - Cancel submission
|
Sandrine Piron
|
|
1 |
|
GCP inspection
|
Venkata Subba Raju Balaraju
|
|
1 |
|
GCP Inspection Managers
|
Karishma Varsani
|
|
1 |
|
Substance registration - orphan designation
|
Thies Dirksmeyer
|
|
1 |
|
Initial Protocol Assistance request when transfer of ODD is ongoing (EC decision pending)
|
Anne-Elisa Maciazek
|
|
1 |
|
Active substance registration
|
Richard Crane
|
|
8 |
|
First placing on the market
|
Elena Cerretini
|
|
1 |
|
Uploading of newly authorised products
|
Robert Castelow-Sturges
|
|
2 |
|
How to delete one MAH in the GVP inspection section?
|
Letizia Vitali
|
|
4 |
|
Unable to see Authorized Products
|
Emanuel Zamora
|
|
2 |
|
Follow-up scientific advice
|
Pia Lorenzen
|
|
4 |
|
Email for public enquiries for Orphan Designation
|
Isha Arora
|
|
4 |
|
IRIS Industry Coordinator role x inspections in IRIS
|
Katerina Anna Klegova
|
|
2 |
|
SA outcome as Reg. Entitlements
|
Isha Arora
|
|
1 |
|
MAH transfers - do products automatically appear in list for Marketing Status Report?
|
Gemma Swaisland
|
|
2 |